Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens-Reference-Cited by-同舟云学术

Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Luo Yong¹,Lin Chaolong¹,Zou Yidi¹,Ju Fei¹,Ren Wenfeng¹,Lin Yanhua¹,Wang Yale¹,Huang Xiaoxuan¹,Liu Huiling¹,Yu Zeng¹,Liu Pingguo²,Tan Guowei³,Yuan Quan¹^ORCID,Zhang Jun¹,Huang Chenghao¹,Xia Ningshao¹^ORCID

Affiliation:

1. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, Fujian, China

2. Department of Hepatobiliary Surgery, Zhongshan Hospital Xiamen University, Xiamen, Fujian, China

3. Department of Neurosurgery, First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

Funder

National Natural Science Foundation of China

National Science and Technology Major Project of China

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1726168

Reference59 articles.